Aurobindo Pharma share price: Aurobindo Pharma shares fall as Nifty gains
The stock quoted a 52-week high of Rs 1063.75 and a low of Rs 584.2. Return on equity for the stock was 24.32%. Around 24,433 shares have changed hands on the counter so far.
The stock’s beta, which measures its volatility relative to the broader market, was 1.06.
The certificate has been an underperformer, down 26.96% over the past year, compared to a 17.8% gain in Sensex.
On the technical charts, the stock’s 200-day moving average (DMA) stood at Rs 584.2 on April 19, while the 50-DMA stood at Rs 663.62. If a stock is trading well above 50-DMA and 200-DMA, it usually means that the immediate trend is up. On the other hand, if the stock is trading well below 50-DMA and 200-DMA at the same time, it is considered to be in a downtrend and if it is trading between these averages, it suggests that the stock can go both ways.
The promoters held a 48.76% stake in Aurobindo Pharma Ltd. as of March 31, 2022. Mutual funds and foreign institutional investors held 10.09% and 20.83% of the capital respectively.